|
|
|
XOMA Corp | 8.375% Depositary Shares Series B Cumulative Perpetual Preferred Stock (XOMAO)
Prospectus excerpt: XOMA Corporation is offering 1,400,000 depositary shares, each representing a 1/1000th fractional interest in a share of 8.375% Series B Cumulative Perpetual Preferred Stock (the “Series B Preferred Stock”), which we refer to in this prospectus as the depositary shares. 1,400 shares of Series B Preferred Stock underlying the depositary shares will be deposited with American Stock Transfer & Trust Company, LLC, as depositary. As a holder of the depositary shares, you will be entitled to all proportional rights, preferences and privileges of the Series B Preferred Stock represented thereby, including dividend, voting, redemption and liquidation rights and preferences. The proportionate liquidation preference of each depositary share is $25.00. Full Prospectus PDF », Secondary Prospectus PDF », XOMA Page »
Series: | B | Redeemable?: | Yes | Call Date: | 4/15/2022 (Now Trading Post Call Date) | Perpetual?: | Yes | Cumulative?: | Yes | Shares Offered: | 1,400,000 | Overallotment: | 200,000 | Liquidation Preference: | $25.00 | Recent Market Price: | $25.40 | Premium to Liquidation Preference: (More Preferreds Trading at a Premium ») | $0.40 (1.60%) | Annualized Dividend: | 2.09376 | Recent Ex-Date: | 4/2/2024 | Current Yield: | 8.24% | Original Coupon: | 8.375% | Pay Period: | Quarterly | Pay Dates: | 15-Jan, 15-Apr, 15-Jul, 15-Oct | CDx3 Compliance Rating: |
Learn XOMAO's Rating
|
|
XOMA is a biotech royalty aggregator. Co. has a portfolio of economic rights to milestone and royalty payments associated with partnered pre-commercial therapeutic candidates. Co.'s portfolio was built through licensing its proprietary products and platforms from its discovery and development business, combined with acquisitions of rights to milestones and royalties. Preferreds: XOMAP, XOMAO Open the XOMA Information Page »
|
|
|
|
|